Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Degner

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 30, 2003
Lack of association between hippocampal volume reduction and first-onset alcohol withdrawal seizure. A volumetric MRI studyS Bleich, W Sperling, D Degner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 17, 2005
Evaluation of oxidative stress measurements in obstructive sleep apnea syndromeW Jordan, S Cohrs, D Degner, et al.
Neuroscience Letters|January 18, 2003
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholismS Bleich, B Bandelow, K Javaheripour, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 25, 2000
Elevated homocysteine levels in alcohol withdrawalS Bleich, D Degner, J Wiltfang, et al.
Acta Neurologica Scandinavica|September 15, 2000
Creutzfeldt-Jakob disease and oxidative stressS Bleich, S Kropp, D Degner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 30, 2009
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic studyM Jäger, M Schmauss, G Laux, et al.
Molecular Psychiatry|October 29, 2003
Erythropoietin: a candidate compound for neuroprotection in schizophreniaH Ehrenreich, D Degner, J Meller, et al.
Molecular Psychiatry|October 13, 2006
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietinH Ehrenreich, D Hinze-Selch, S Stawicki, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 30, 2003
Lack of association between hippocampal volume reduction and first-onset alcohol withdrawal seizure. A volumetric MRI studyS Bleich, W Sperling, D Degner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 17, 2005
Evaluation of oxidative stress measurements in obstructive sleep apnea syndromeW Jordan, S Cohrs, D Degner, et al.
Neuroscience Letters|January 18, 2003
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholismS Bleich, B Bandelow, K Javaheripour, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 25, 2000
Elevated homocysteine levels in alcohol withdrawalS Bleich, D Degner, J Wiltfang, et al.
Acta Neurologica Scandinavica|September 15, 2000
Creutzfeldt-Jakob disease and oxidative stressS Bleich, S Kropp, D Degner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 30, 2009
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic studyM Jäger, M Schmauss, G Laux, et al.
Molecular Psychiatry|October 29, 2003
Erythropoietin: a candidate compound for neuroprotection in schizophreniaH Ehrenreich, D Degner, J Meller, et al.
Molecular Psychiatry|October 13, 2006
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietinH Ehrenreich, D Hinze-Selch, S Stawicki, et al.
Pageof 5